| ACE2 | angiotensin converting enzyme 2 |
| ACEi | angiotensin converting enzyme inhibitor |
| Ang II | angiotensin II |
| AP | aminopeptidases |
| ARB | angiotensin receptor blockers |
| ARDS | acute respiratory distress syndrome |
| ASA | aldosterone synthase antagonist |
| AT1R/AT2R | angiotensin type 1/2 receptor |
| B1R/B2R | bradykinin type 1/2 receptor |
| BP | blood pressure |
| BK | bradykinin |
| COVID-19 | coronavirus disease 2019 |
| CVCs | cardiovascular complications |
| CPM | carboxypeptidase M |
| DABK | des-Arg9-bradykinin |
| DAKD | des-Arg10-kallidin |
| DPPD-4 | dipeptidyl peptidase 4 |
| GPCRs | G protein-coupled receptors |
| ICU | intensive care unit |
| IFN | interferon |
| IL-6 | interleukin-6 |
| KD | kallidin |
| KKS | kinin–kallikrein system |
| NETs | neutrophil extracellular traps |
| NLRP3 | NOD-, LRR- and pyrin domain-containing protein 3 |
| RAAS | renin–angiotensin–aldosterone system |
| ROS | reactive oxygen species |
| SARS-CoV-2 | severe acute respiratory syndrome coronavirus 2 |
| TMPRSS2 | transmembrane protease serine 2 |
| TNFα | tumour necrosis factor α |